1. Home
  2. ESLA

ESLA

Estrella Immunopharma Inc.

Logo Estrella Immunopharma Inc.

Health Care

Biotechnology: Biological Products (No Diagnostic Substances)

Nasdaq

as 04-19-2024 4:00pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Estrella Immunopharma Inc is a preclinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer.

Founded: 2021 Country:
United States
United States
Employees: N/A City: EMERYVILLE
Market Cap: 41.4M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 31.9K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -2.90 EPS Growth: N/A
52 Week Low/High: $0.86 - $33.00 Next Earning Date: 05-03-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: